BioSpace News Archive

Genetown

BVI Announces Certification for its Intraocular Lens Portfolio under the European Medical Device Regulation

BVI, a diversified global ophthalmic device company, today announced certification for its intraocular lens (IOL) portfolio under the European Medical Device Regulation (MDR, (EU) 2017/745) from its Notified Body, the British Standards Institution (BSI)¹.

September 15, 2022
·
2 min read
Business

Tiziana Life Sciences Announces Grant received by the Brigham and Women’s Hospital to Explore the Use of Intranasal anti-CD3 mAb in Amyotrophic Lateral Sclerosis

Tiziana Life Sciences Ltd. today announces that a Lawrence & Isabel Barnett Drug Development Program Grant will be awarded to the Ann Romney Center for Neurologic Diseases at the Brigham and Women’s Hospital (BWH) by the ALS Association for the study of an intranasal anti-CD3 monoclonal antibody.

September 15, 2022
·
4 min read
Pharm Country

Aptorum Group Updates on the Clinical Validation of RPIDD Infectious Disease Liquid Biopsy Molecular Diagnostics

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) , is pleased to announce further updates on the analytical and both the retrospective and prospective clinical validation of the RPIDD technology in patient samples, employed under both Illumina iSeq 100 and MiniSeq sequencing platforms.

September 15, 2022
·
8 min read
Genetown

Carver Biosciences Launches with Seed Financing to Advance CRISPR/Cas13-based Technologies

Carver Biosciences, Inc., a biotech company focused on the development of CRISPR/Cas13 antivirals, today announced the closure of a seed round of funding, led by Khosla Ventures.

September 15, 2022
·
3 min read
Business

Diality Names Pamela Wapnick as Chief Financial Officer

Diality Inc., a medical technology company developing a smart, mobile hemodialysis platform, today announced the hiring of Pamela Wapnick as chief financial officer.

September 15, 2022
·
3 min read
Business

Newron provides H1 2022 results and updates on R&D and business activities

Newron provides H1 2022 results and updates on R&D and business activities.

September 15, 2022
·
13 min read
CloudMD’s TAiCBT Results in Significant Improvement for PTSD Across Symptom Severity Levels, Trauma Types and Demographics

CloudMD Software & Services Inc. today released a research study that demonstrates the positive outcome results from using its therapist-led internet based cognitive behavioural therapy (TAiCBT) for individuals suffering from posttraumatic stress disorder.

September 15, 2022
·
10 min read
BioCapital

Alphyn Biologics Closes $3.3 Million Series A Financing to Advance Breakthrough Atopic Dermatitis Treatment

Alphyn Biologics , a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced today that it is has closed a Series A financing round of approximately $3.3 million.

September 15, 2022
·
3 min read
Business

Pasithea Therapeutics Further Strengthens its Scientific Advisory Board with the Appointment of Dr. Merit Cudkowicz

Pasithea Therapeutics Corp. today announced the appointment of Dr. Merit Cudkowicz to its Scientific Advisory Board.

September 15, 2022
·
3 min read
FDA

Jasper Therapeutics Announces FDA Fast Track Designation for JSP191, a novel monoclonal antibody targeting CD117

Jasper Therapeutics, Inc. has received fast track designation from the U.S. Food and Drug Administration (FDA) for the treatment of patients with severe combined immunodeficiency (SCID) undergoing allogeneic hematopoietic stem cell transplant.

September 15, 2022
·
8 min read